| Price | 6.70p on 06-05-2026 at 11:37:20 |
|---|---|
| Change | -0.30p -4.29% |
| Buy | 6.80p |
| Sell | 6.60p |
| Last Trade: | Buy 29,419.00 at 6.79p |
| Day's Volume: | 7,506,527 |
| Last Close: | 7.00p |
| Open: | 6.95p |
| ISIN: | GB00BYV81293 |
| Day's Range | 6.45p - 6.74p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £71.58m |
| VWAP: | 6.677043p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 29,419 | 6.79p | Ordinary |
12:37:18 - 06-May-26 |
| Buy* | 58,765 | 6.80p | Ordinary |
12:36:50 - 06-May-26 |
| Buy* | 40,000 | 6.80p | Ordinary |
12:35:10 - 06-May-26 |
| Buy* | 50,000 | 6.7998p | Ordinary |
12:33:51 - 06-May-26 |
| Buy* | 220,588 | 6.80p | Ordinary |
12:31:12 - 06-May-26 |
| Buy* | 58,903 | 6.784p | Ordinary |
12:30:23 - 06-May-26 |
| Buy* | 147,412 | 6.78p | Ordinary |
12:29:45 - 06-May-26 |
| Buy* | 21,983 | 6.78p | Ordinary |
12:29:16 - 06-May-26 |
| Buy* | 73,746 | 6.78p | Ordinary |
12:28:15 - 06-May-26 |
| Buy* | 25,000 | 6.78p | Ordinary |
12:28:12 - 06-May-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th May 2026 7:00 am | RNS | Grant of Share Options |
| 1st May 2026 7:00 am | RNS | Q1 2026 Trading Update |
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
